Weight Gain Is Associated with Medial Contact Site of Subthalamic Stimulation in Parkinson's Disease by Růžička, Filip et al.
Weight Gain Is Associated with Medial Contact Site of
Subthalamic Stimulation in Parkinson’s Disease
Filip Ru ˚z ˇic ˇka
1., Robert Jech
1*
., Lucie Nova ´kova ´1, Dus ˇan Urgos ˇı ´k
2, Josef Vymazal
3, Evz ˇen Ru ˚z ˇic ˇka
1
1Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic,
2Department of Stereotactic and Radiation Neurosurgery, Na Homolce Hospital, Prague, Czech Republic, 3Department of Radiology, Na Homolce Hospital, Prague, Czech
Republic
Abstract
The aim of our study was to assess changes in body-weight in relation to active electrode contact position in the
subthalamic nucleus. Regular body weight measurements were done in 20 patients with advanced Parkinson’s disease
within a period of 18 months after implantation. T1-weighted (1.5T) magnetic resonance images were used to determine
electrode position in the subthalamic nucleus and the Unified Parkinson’s disease rating scale (UPDRS-III) was used for
motor assessment. The distance of the contacts from the wall of the third ventricle in the mediolateral direction inversely
correlated with weight gain (r=20.55, p,0.01) and with neurostimulation-related motor condition expressed as the
contralateral hemi-body UPDRS-III (r=20.42, p,0.01). Patients with at least one contact within 9.3 mm of the wall
experienced significantly greater weight gain (9.46(SD)4.4 kg, N=11) than those with both contacts located laterally
(3.962.7 kg, N=9) (p,0.001). The position of the active contact is critical not only for motor outcome but is also associated
with weight gain, suggesting a regional effect of subthalamic stimulation on adjacent structures involved in the central
regulation of energy balance, food intake or reward.
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Introduction
Deep brain stimulation of the subthalamic nucleus (STN-DBS)
is a remarkably effective method for treating motor manifestations
of advanced Parkinson’s disease (PD). In addition, a variety of non-
motor effects related to STN-DBS have been described, including
weight gain. Although the precise mechanism underlying changes
in body weight has yet to be determined, several hypotheses have
been advanced [1]. Some authors have suggested that weight gain
may be related to changes in medication, especially to the
reduction of dopaminergic drugs [2,3,4]. Others have emphasized
that weight gain may be related to the normalization of energy
expenditure due to decreased rigidity and the amelioration of
dyskinesia [5,6]. Additionally, changes in weight could reflect the
direct influence of STN-DBS on adjacent structures involved in
the regulation of eating behavior or energy balance [3,5,7].
It has been proposed that DBS may cause the excitation of
axons surrounding the electrode and increased output from
stimulated nuclei [8,9]. The spread of current has been estimated
to occupy approximately a 2–4 mm radius around the electrode
contact [10,11,12]. Given structural and functional complexity of
the subthalamic area, it is believed that the diffusion of stimulation
current to its different parts plays a role in motor improvement as
well as in the various side effects of DBS [10,11]. From this
perspective, it is conceivable that the stimulating DBS electrode
could influence body weight, especially if it was close to the
structures involved in the regulation of energy expenditure, food
intake or reward, such as the lateral hypothalamic area [13,14],
medial forebrain bundle [15] or the limbic part of the STN
[16,17,18]. Notably, all of these structures lie in the medial part of
the subthalamic area [19,20]. On the other hand, in terms of
motor improvement, subthalamic stimulation appears to be most
effective in the dorsolateral border of the nucleus (sensorimotor
part) [21,22,23]. Thus, the position of active contact relative to the
intrinsic organization of the STN might differentially contribute to
motor effects and weight changes.
Therefore, the aim of our study was to assess whether weight
gain observed in PD patients treated by STN-DBS is dependent
on the active electrode contact position in the STN, particularly
with respect to mediolateral direction.
Methods
Patients and weight measurement
Regular body weight measurements were made on the day of
surgery and one, two, four, six, twelve and eighteen months after
electrode implantation in 20 patients with advanced PD (6 women,
14 men; mean age 56.66(SD)5.8 years; disease duration 13.264.5
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e38020years). Demographic data of the patients that participated in the
study are summarized in table 1. A maximum change in weight
during the study period and weight change at the 18th month were
considered in each patient. Weight changes were expressed in
absolute values as well as in percentage of initial body weight.
Eating related questionnaires were administered at each visit.
Food intake, hunger, general appetite and preference for sweet
food were rated by patients as (0) without any change, (21) lower
or (+1) higher than at the previous visit. All patients provided
written, informed consent for participation in the study and the
study was approved by the Ethics Committee of the General
University Hospital in Prague, Czech Republic.
Surgical procedure and stimulation settings
Bilateral DBS electrode implantation (model 3389, Medtronic,
Minneapolis, MN, USA) was guided by MRI-based stereotaxy,
microelectrode recordings and the test stimulation procedure as
described elsewhere [24]. Within three days the electrodes were
connected to a subcutaneously implanted pulse generator (Kine-
tra, Medtronic). Stimulation was initiated one month following
implantation when each patient underwent standard screening of
all electrode contacts in an off-medication state. Finally, one
contact on each side and stimulation settings using a monopolar or
bipolar (in one patient) setting were selected to obtain the best
motor outcome. In the following month, the stimulation intensity
was gradually increased (Figure 1) while dopaminergic medication
was in most cases reduced to further optimize the motor outcome.
For the purpose of our study, stimulation intensity was calculated
as the mean of arithmetic products of all the parameters from both
neurostimulators (I-intensity, u-voltage, d-pulse duration, f-fre-
quency): I=(uL.dL.fL+uR.dR.fR)/2 [25]. At month 18, the stimu-
lation parameters were 2.860.5 V, 60–120 ms and 130 Hz and
the mean stimulation intensity was 2.860.8. 10
4 V ms Hz.
Table 1. Clinical description of PD patients treated with subthalamic deep brain stimulation.
gender
age at
surgery (yrs)
PD duration
before surg.
(yrs)
UPDRSIII
s-OFF
UPDRSIII
s-ON
initial BMI
(kg/m
2)
initial body
weight (kg)
maximum weight
gain (kg)
1 F 53 20 30 17 19,9 53,3 18,3
2 F 63 18 32 17 17,8 50,1 14,9
3 M 65 22 44 24 23,2 84,2 12,3
4 F 61 12 43 28 24,4 65,6 12
5 M 53 15 62 22 22 69,6 9,4
6 F 58 10 37 17 26,6 64,1 7,5
7 M 56 12 41 23 30,9 100 7,2
8 M 57 14 30 26 20,6 71,3 7,2
9 M 55 7 25 18 27,5 86 7
10 M 67 11 32 16 28,2 86,4 6,5
11 F 58 7 37 18 22,4 61,6 6,4
12 F 42 23 53 19 33,3 80 6
13 M 48 14 36 17 21,6 70 5,3
14 M 56 13 39 16 27,7 95,2 4,5
15 M 49 11 25 12 25,1 67,5 4,1
16 M 57 15 44 11 26,8 84,8 3,9
17 M 63 10 35 14 25,8 72,9 3,6
18 M 58 9 36 24 25 76,6 2,1
19 M 57 10 35 12 28,3 86,8 0,2
20 M 55 10 18 5 29,8 112,3 20,3
F – female, M – male; PD – Parkinson’s disease; UPDRS-III – motor subscore of the Unified Parkinson’s Disease Rating Scale; sOFF – postoperative off-neurostimulation
state; sON – postoperative on-neurostimulation state; BMI – body mass index; initial body weight – body weight assessed before implantation; maximum weight gain –
maximum weight change over the whole study period.
doi:10.1371/journal.pone.0038020.t001
Figure 1. Mean stimulation intensity (6SD) of the STN-DBS at
1, 2, 4, 6, 12 and 18 months after implantation in 20 patients
with Parkinson’s disease. The stimulation intensity was calculated as
the arithmetic product of the I-intensity, u-voltage, d-pulse duration
and f-frequency from both hemispheres (uL.dL.fL+uR.dR.fR)/2. The
stimulation intensity was gradually increasing during the study to
optimize the motor outcome.
doi:10.1371/journal.pone.0038020.g001
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Motor status was evaluated using the motor subscore of the
Unified Parkinson’s Disease Rating Scale (UPDRS-III). Each
subject was examined postoperatively under two conditions at least
12 hours after discontinuing all antiparkinsonian drugs: (1) in the
off-neurostimulation state (sOFF) and (2) in the on-neurostimula-
tion state (sON). The change of motor status induced by
stimulation was expressed as the percentage of UPDRS-III (100-
100sON/sOFF). Additionally, hemi-body subscores derived from
the UPDRS-III (items 20–26) were calculated as the sum of limb
ratings of ridigity, akinesia and tremor, separately for the left and
right extremities.
Assessment of active contact position
Magnetic resonance images were acquired at 1.5 T on a Siemens
Avanto system (Siemens, Erlangen, Germany) in each patient
approximately one year after DBS implantation. To obtain better
image resolution, sagittal (0.9 mm isotropic) and axial
(16161.6 mm) T1-weighted magnetization-prepared rapid acqui-
sition gradient-echo (MPRAGE) images were automatically co-
registered and averaged using SPM5 software (Wellcome Trust
Centre for Neuroimaging, London, UK).
All four contacts (0,1,2,3) of the DBS electrode produced well-
defined susceptibility artifacts on the T1-MPRAGE image in each
patient [26]. While the coordinates of contacts 0 and 3 were
established directly from the center of the distal and proximal
artifacts using MRIcro 1.40 software (www.cabiatl.com/mricro),
the coordinates of contacts 1 and 2 were calculated. The x-
coordinate of each contact was measured from the wall of the third
ventricle, whereas the y- and z-coordinates were measured from
the midcommisural point. Two coordinate systems, native and
normalized, were used in the study. During linear normalization,
all dimensions were manually adjusted with respect to the
standardized AC-PC length, to the distance of the midcommis-
sural point from the lateral edge of the putamen, and to the
distance of the optic tract from the dorsal edge of the putamen.
Finally, the active contacts in both hemispheres were plotted on
axial (xy), coronal (xz) and sagittal (yz) planes covering the whole
subthalamic area.
Analysis
Statistical analysis was performed using SPSS 14.0.1 software
(SPSS Inc, Chicago, IL, USA). For parameters with normal
distribution, parametric tests (one sample t-test, paried t-test,
Pearson correlation analysis) were used. The others were assessed
with the non-parametric tests (Friedman test, Spearman rank
correlation analysis).
Primary outcomes of the study were based on the maximum
weight gain throughout the study and on the hemibody UPDRS-
III in the sON state after initiation of neurostimulation. Their
dependence on active contact position was analyzed for each x, y
and z-axis separately by Pearson correlation analysis when
considering the left and right hemispheres independently, as well
as for all active contacts pooled bilaterally taking into account only
one active contact (more medial or lateral contact from both
hemispheres) in each patient.
In addition, we systematically sought a border dividing the
subthalamic area into regions with higher and lower risk of weight
gain. To do so, we compared weight gain relative to the active
contact position in the subthalamic area divided into two regions
of interest (ROI) by a movable yz-plane in the mediolateral
direction (x-axis). The iterative general linear model (GLM) was
used to compare weight gain in patients with at least one contact
within one ROI and patients with both contacts in the other ROI.
The factor GENDER and covariates AGE and TIME of
postoperative maximum weight gain were included to control
for possible confounding effects. The division yz-plane was then
successively moved along the x-axis by 0.5–1 mm steps to define
a BORDER with lowest p-value. A similar approach was used to
compare weight gain considering active contacts in two sub-
thalamic ROIs separated by a movable xz-plane in the ante-
roposterior direction (y-axis) and by the xy-plane in the
ventrodorsal direction (z-axis).
Relationships between body weight, motor performance, eating
behavior and intensity of stimulation were assessed separately as
secondary outcomes. As they were based on multiple comparisons,
the Bonferroni correction was applied whenever appropriate.
Results
After initiation of STN DBS, the UPDRS-III score dropped on
average from 36.76(SD)9.6 (sOFF) to 17.865.5 (sON) (T=7.3,
p,10
27) showing good efficacy of neurostimulation treatment.
The maximum change in body weight in the eighteen-month
period after implantation was on average +6.9 kg64.5 kg (20.3 to
+18.3 kg) and was strongly significant (T=6.6, p,10
25). Despite
gradually increasing weight during the entire study period
(Figure 2), nine patients reached the maximum body weight
within the first 6 months after surgery, five patients in months 6–
12 and six patients in months 12–18 after surgery.
As the analyses of active contact coordinates derived from
native and normalized approaches yielded similar results, only
statistics based on coordinates in native space are reported. In
individual patients, the maximum weight gain correlated inversely
along the x-axis with the distance of the active contact from the
wall of the third ventricle in the left hemisphere (r=20.48,
p,0.05), right hemisphere (r=20.50, p,0.05), and in pooled
data (r=20.55, p,0.01) if only more medial active contact
regardless to hemisphere was considered (Figure 3). Similar results
were obtained for maximum weight gain expressed in percentage
of initial body weight as well as when considering weight gain at
the end of the 18th month. In addition, the hemi-body UPDRS-III
subscores in sON condition inversely correlated with the distance
of the contralateral active contact from the wall of the third
ventricle in the mediolateral direction (r=20.42, p,0.01)
(Figure 4). However, none of these parameters showed any
relation to the active contact position along the y-axis or z-axis.
Figure 2. Mean changes in weight after implantation in 20
patients with Parkinson’s disease. Body weight gradually increased
during the study period. Weight gain represents the difference in
weight (6SD) compared to the preoperative state.
doi:10.1371/journal.pone.0038020.g002
Subthalamic Electrode Position and Weight Gain
PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e38020With the iterative moving plane approach, we found a border
orthogonal to the x-axis dividing the subthalamic area into two
ROIs that differed in postoperative weight gain. Patients with at
least one active contact within 9.3 mm of the wall of the third
ventricle demonstrated significantly greater weight gain
(9.464.4 kg, N=11) than those patients with both contacts
located more laterally from the wall (3.962.7 kg, N=9) (GLM,
factor BORDER: F=16.1, p,0.001)(Figure 5). The postoperative
maximum weight gain significantly differed between genders, with
a greater increase in women (N=6, 10.96(SD)4.8 kg) than in men
(N=14, 5.263.4 kg) (GLM, factor: GENDER, F=10.7, p,0.01).
However, no other covariates (factor AGE: F=0.001, p=0.99;
factor TIME: F=0.002, p=0.96) nor interactions between
BORDER, GENDER, AGE and TIME were significant.
In addition, the postoperative maximum weight gain in all
patients inversely correlated with preoperative body weight
(r=20.62, p,0.05 corrected). Maximum weight gain did not
significantly depend on UPDRS-III improvement after switching
the stimulation on (r=238, p=0.1), and no correlation between
weight gain at the 18th month and stimulation intensity was found.
Analysis of eating behavior failed to demonstrate any change in
hunger, appetite, preference for sweet food or food intake in our
patients. However, there was a positive correlation between food
intake and body-weight gain at the 18th month (rho=0.66,
P,0.05 corrected).
Discussion
We observed weight gain inversely related to the distance of the
contacts from the wall of the third ventricle (Figure 3), and patients
with at least one contact located medially in the STN experienced
significantly greater weight gain than those with both active
contacts located laterally (Figure 5). Thus, our results are
consistent with the hypothesis that STN-DBS exerts a regional
effect on adjacent structures involved in energy balance. In
addition, our findings are also in agreement with reports of weight
gain observed after unilateral STN-DBS [27,28]. As the position of
each implanted electrode was verified by intraoperative micro-
recording and DBS caused clear motor improvement, we believe
that our observations are not affected by electrode misplacement
outside the STN. However, no correlation between stimulation
intensity (Figure 1) and weight gain (Figure 2) was found in our
study. This may be partly explained by low variability of
stimulation parameters between patients or limited size of the
patient group.
The maximum weight gain in our study was significantly larger
in women than in men. Although women may be more susceptible
to weight gain [29], previous studies have proven no significant
sex-related differences in weight gain after unilateral or bilateral
STN-DBS [2,4,5,7,27,28]. These findings are in agreement with
our observation that weight gain in all six women of our study was
associated with the medial contact site and that no interaction
between active contact position and gender was found.
Similar to other studies [21,22,23], we found an inverse
correlation between unilateral motor outcome (measured for
rigidity, akinesia and tremor using hemi-body UPDRS-III sub-
score) and contralateral position of the active contact (Figure 4).
Thus, patients with the lowest motor score (best motor condition)
had contacts located more laterally from the wall of the third
ventricle. Such results most likely reflect the internal organization
of the STN with the sensorimotor part located dorsolaterally in the
nucleus [20].
However, we did not observe any significant correlation
between weight gain and change in UPDRS-III score. This
finding is consistent with those published previously [2,4,30] and
may indicate that the connection between changes in weight and
motor outcomes is not as straightforward as has been proposed
[31]. Unrelated weight gain to motor outcome was also shown in
another study in which weight gain was more pronounced in
patients with subthalamic stimulation than in patients with pallidal
stimulation, despite similar motor improvement in both groups
[30]. Thus, additional factors likely contribute to greater weight
gain in subthalamic stimulation.
The central mechanism by which STN-DBS might cause
weight gain remains unclear. It could be hypothesized that the
spread of stimulation current beyond the borders of the STN may
influence the hypothalamic regulation of energy metabolism or the
Figure 3. Weight gain in 20 patients with Parkinson’s disease in
relation to the mediolateral position of the active contact with
bilateral STN-DBS (r=20.55, p,0.01). Only one active contact
(more medial contact from both hemispheres) was used in each patient.
The x-coordinate represents the distance of the active contact from the
wall of the third ventricle. Each millimeter in the medial direction was
associated on average with a 1.6-kg increase in body weight. Dotted
lines denote the 95% confidence interval of the regression line.
doi:10.1371/journal.pone.0038020.g003
Figure 4. Hemi-body UPDRS-III subscores in the sON condition
after overnight withdrawal of dopaminergic therapy in re-
lation to the mediolateral position of the contralateral active
contact. After initiation of STN-DBS, the hemi-body side with the
lowest motor score (best motor condition) had the contralateral
contacts located more laterally from the wall of the third ventricle
(r=20.42, p,0.01). Dotted lines denote the 95% confidence interval of
the regression line.
doi:10.1371/journal.pone.0038020.g004
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only a few studies on the effects of long-term STN-DBS on
autonomic [32,33,34] or hormonal systems [35], and they have
provided no clear explanation for weight gain.
Conversely, increased food intake by non-homeostatic or
reward mechanisms may also provide a compelling hypothesis.
The medial tip of the STN is involved in basal ganglia limbic and
motivational functions [16,17,18,36]. It is connected to key
structures of the reward system such as the ventral pallidum and
the ventral tegmental area [37,38,39]. It has been shown that
STN-DBS can affect the neural activity of these structures, as well
as increase dopaminergic transmission in the striatum [40,41,42].
Moreover, the medial part of the STN is adjacent to the medial
forebrain bundle which contains essential projections underlying
reward functions [15]. Extensive research has demonstrated a close
relationship between the mesolimbic system, medial forebrain
bundle and ventral pallidum in motivational desire for food
rewards, increase in food intake and obesity [43,44,45,46].
Therefore, it seems plausible that an active electrode in the
proximity of the medial STN could be ideally positioned to
stimulate the reward system, thereby contributing to changes in
motivational behaviors related to food intake and weight gain. Our
previous study supports this hypothesis, as it revealed that
postoperative weight gain correlated with arousal ratings from
food pictures in the STN-DBS ON condition, suggesting an
altered attribution of incentive salience (i.e., emotional relevance)
to rewarding stimuli [47].
Although most of the subjects did not report any changes in
food intake, hunger or appetite in our study, the inaccuracy of self-
reported intake [48,49,50] should prompt caution in the in-
terpretation of these results. Food intake depends largely on
reward or homeostatic systems and is only partly under cognitive
control [45,51,52]. We can hypothesize that slight individual
changes in motivational behavior and reward system induced by
DBS of subcortical structures need not be reflected in subjective
feelings such as hunger or appetite [47,53]. Further prospective
studies taking into account changes in sensitivity to reward [45]
and actual food intake would be necessary to clarify this question.
In agreement with another study [7], we found a significant
inverse correlation between preoperative body weight and post-
operative weight gain. Since weight has been reported to decrease
with PD progression [54], it has been suggested that patients
treated with DBS normalize their weight compared to their
premorbid status because of motor improvement [4,5]. However,
this hypothesis cannot fully account for the fact that although most
patients indicated for DBS are normal weight or overweight, the
majority of them experience continuous weight gain after surgery
[2,7]. Yet it seems that changes in motor manifestations and
energy expenditure can only partly explain both the weight loss in
PD and weight gain after initiation of DBS [30,54,55]. It has been
shown that overweight and obese individuals have higher
sensitivity to reward which predicts the tendency for overeating
and strengthens preferences for sweet and fatty foods [45]. We
speculate that if STN-DBS increases sensitivity to reward in
relation to the medial contact site in the subthalamic area, thereby
modulating eating behavior, this effect would be more pronounced
especially in patients with preoperatively lower body weight, lower
sensitivity to reward and without previous, excessive caloric intake.
Some limitations have to be taken into account when
interpreting our results. Since body weight may be reflected in
local white matter changes [29] and the size and position of the
STN varies [56,57] to some extent relative to the midcommisural
point, the influence of anatomic variability cannot be excluded
from our measurements. However, we compensated for the
variable width of the third ventricle, which significantly affects the
mediolateral position of the STN [57,58], by measuring the x-
coordinate from the wall of the third ventricle.
In conclusion, our findings support the hypothesis that weight
gain in PD patients treated by STN-DBS may, at least in part,
result from the regional effect of stimulation on adjacent structures
involved in the central regulation of energy balance or reward.
Figure 5. Bilateral STN-DBS active contact positions of 20 patients with Parkinson’s disease plotted in the coronal plane with
respect to weight gain. Patients (N=11) with at least one active contact (a) placed within 9.3-mm of the wall of the third ventricle gained
significantly more weight than patients (N=9) with both contacts (b) located more laterally (p,0.001).
doi:10.1371/journal.pone.0038020.g005
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